SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,792 | -90.0% | 303,215 | -35.0% | 0.00% | – |
| Q2 2023 | $557,748 | +129008.3% | 466,735 | -25.3% | 0.00% | – |
| Q1 2023 | $432 | -15.0% | 624,862 | -16.5% | 0.00% | – |
| Q4 2022 | $508 | -99.9% | 747,985 | -18.6% | 0.00% | -100.0% |
| Q3 2022 | $947,000 | -12.3% | 919,068 | -42.1% | 0.00% | 0.0% |
| Q2 2022 | $1,080,000 | +496.7% | 1,586,989 | +634.7% | 0.00% | – |
| Q1 2022 | $181,000 | -85.4% | 216,005 | -71.5% | 0.00% | -100.0% |
| Q4 2021 | $1,236,000 | -62.0% | 758,295 | -43.8% | 0.00% | -50.0% |
| Q3 2021 | $3,254,000 | -34.4% | 1,350,283 | -28.1% | 0.00% | -33.3% |
| Q2 2021 | $4,959,000 | +54.2% | 1,878,474 | +191.4% | 0.00% | +50.0% |
| Q1 2021 | $3,216,000 | +1409.9% | 644,543 | +918.3% | 0.00% | – |
| Q1 2019 | $213,000 | – | 63,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |